Development of Optical Biometer
Recruiting
N/A
Interventional Study
Cataract and IOL Surgery
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Cassini Technologies · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Helioscope (Cassini Technologies B.V.) is a novel device under development that aims at combining LED-based corneal topography and SS-OCT to provide accurate and fast measurements of both the corneal shape and the ocular biometry. To that end, the hardware and software of the Cassini color-LED topographer (Cassini Technologies B.V.) is combined with a novel SS-OCT device.
While the new Helios…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* The presence of cataract in at least one eye.
* Minimally 21 years of age.
* Provided written informed consent.
Exclusion criteria:
* The inability to properly fixate on a fixation target for several seconds
* The inability to provide informed consent.
Contacts